This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
02/09/16 - 3:59:56 PM ET (BATS BZX Real-time Price)
Div Yield: --
PSDV Day's Range
PSDV 52 Week Range
PSDV Business Summary
pSivida Corp. develops sustained-release drug-delivery products for treating eye diseases in the United States and the United Kingdom.View PSDV
pSivida Corp - PSDV - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates pSivida Corp as a
Sell with a ratings score of D.
Report Snippet: We rate PSIVIDA CORP (PSDV) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.